Approved labelMIMRYLO prescribing information for erythrocytosis in adults with polycythemia vera
Start 19 mg
9.5 mg108 mg
- 54 mg Above this, two injections
- 82 mg Above this, given on separate days
Label cadence: once weekly.
PopulationAdults with polycythemia vera and erythrocytosis
DoseStart at 19 mg once weekly. The label permits dose increases after at least 2 weeks at the current dose, following its titration table, to keep hematocrit below 45%. The recommended range is 9.5 mg to 108 mg once weekly. Doses above 54 mg require two injections. Doses greater than 82 mg should be administered on separate days.
RouteSubcutaneous injection in the abdomen or thigh, or the upper arm when given by a caregiver
FrequencyOnce weekly. Doses above 54 mg require two injections, and doses above 82 mg are given on separate days (day 1 and day 4 or 5).
DurationLong-term use within the approved indication, with complete blood counts every 2 to 4 weeks during dose modifications
PreparationLyophilized powder in 9.5 mg, 19 mg, 28 mg, 41 mg and 54 mg single-dose vials, co-packaged with a diluent prefilled syringe. Reconstitute with the provided diluent, swirl for about 2 minutes and do not shake. Use within 4 hours at 20 to 25 degrees C. Store at room temperature, do not freeze and protect from light.